Digitalis obscura die if left in wet soil over winter. "Digitalis obscura" grows in either full or partial sun. It blooms during late spring from May to June and spreads over the ground about 0.75–1.5 feet. Once established, it is perennial and grows at a rather moderate to fast pace. It is non-invasive and attracts hummingbirds. It is naturally resistant to deer and rabbits. "Digitalis obscura" is a shrub that grows about tall. The stems are smooth and erect. The long leaves are basal and form in a rosette fashion growing outward closer to the ground. Smaller leaves grow alternately along the
New Drug Application Review should complete within 6 months. The decision comes in a "Complete Response Letter". Biologics, such as vaccines and many recombinant proteins used in medical treatments are generally approved by FDA via a Biologic License Application (BLA), rather than an NDA. The manufacture of biologics is considered to differ fundamentally from that of less complex chemicals, requiring a somewhat different approval process. Generic drugs that have already been approved via an NDA submitted by another maker are approved via an Abbreviated New Drug Application (ANDA), which does not require all of the clinical trials normally required for a new drug